Abstract:OBJECTIVE:To screen and identify peptides that binds specifically to gastric cancers cells with high metastasis to peritoneum so as to find appropriate vectors for targeting therapy for cancer.METHODS:Human gastric cancer cells of the line GC9811 and those with high metastasis to peritoneum of the line GC9811-P were co-incubated with the 12-mer bacteriophage random peptide library. After 3 round of repeated screening, phage clones were collected. Forty internalized phage single-stranded DNA that specifically binding to the GC98112-P cells were sequenced. GC9811 and GC9811-P cells were co-inoculated with 5 peptides with the N end marked with fluorescein isothiocyanate (FITC) and 1 un-related peptide not binding to GC9811 and GC9811-P cells. Fluorescence microscopy, ELISA, and flow cytometry were used to detect the binding activity. BALB/cnu/nu mice were inoculated intraperitoneally with GC9811 and GC9811-P cells and then randomly divided into. 2 equal groups: experimental group, inoculated with the peptide PIII-FITC and control group (inoculated with un-related peptide PC-FITC. Forty-eight hours later the mice were killed and the peritoneum and tumor masses in different organs were collected and under fluorescence microscopy.RESULTS:DNA sequencing showed that 45% (18/45) of the isolated phages displayed repeated sequence SMSIASPYIALE, and SMSI was defined as a conservative motif. Obvious fluorescence was seen in the GC9811-P cells co-incubated with PIII-FITC and weak fluorescence was seen in the GC9811 cells co-incubated with PIII-FITC. Un-marked un-related peptide PC and PIII-FITC did not influenced the fluorescence staining of the GC9811-P cells, however, no fluorescence could be seen in the GC9811-P cells co-incubated with un-marked PIII and PIII-FITC. The fluorescence positive cell rate was 5.9% in the GC9811 cells co-incubated with PIII-FITC, and was 90.2% in the GC9811-P cells co-incubated with PIII-FITC. The fluorescence positive cell rates of the GC9811 cells and GC9811-P cells co-incubated with PC-FITC were 10.1% and 9.9% respectively 10.1% and 9.9% respectively. The fluorescence strength of the GC9811-P cells co-incubated with PIII-FITC was significantly greater than that of the GC9811-P cells co-incubated with PC-FTIC at any time-point and dose (all P < 0.01), and increased along with the increase of co-incubation time and dose of PIII-FITC. The peritoneal tumor tissues caused by the GC9811-P cells of the mice showed strong fluorescence and those caused by GC9811 cells only showed very weak fluorescence. Weak fluorescence could be seen in the tumor masses in the lymph nodes, liver, and muscle of the mice inoculated with GC9811-P cells and was not seen in the tissues of the mice inoculated with GC9811 cells.CONCLUSION:The sequence SMSIASPYIALE that specifically binds to human gastric cancer cells with high metastasis has been screened that has the potential to be used as a marker and targeting vector in diagnosis and treatment of gastric cancer.

Specific Targeting of the Vasculature of Gastric Cancer by a New Tumor-Homing Peptide CGNSNPKSC.

188Re-Labeled GX1 Dimer As a Novel Dual-Functional Probe Targeting TGM2 for Imaging and Antiangiogenic Therapy of Gastric Cancer

A Novel Peptide (GX1) Homing to Gastric Cancer Vasculature Inhibits Angiogenesis and Cooperates with TNF Alpha in Anti-Tumor Therapy

<SUP>68</SUP>Ga-Labeled GX1 Dimer: A Novel Probe for PET/Cerenkov Imaging Targeting Gastric Cancer

Novel Peptide GX1 Inhibits Angiogenesis by Specifically Binding to Transglutaminase-2 in the Tumorous Endothelial Cells of Gastric Cancer

Characterization of a specific phage-displayed Peptide binding to vasculature of human gastric cancer.

The Tumour Neovasculature-Homing Dimeric Peptide GX1 Demonstrates Antiangiogenic Activity in the Retinal Neovasculature

In Vivo Gastric Cancer Targeting and Imaging Using Novel Symmetric Cyanine Dye-Conjugated GX1 Peptide Probes

Screening and Identification of Vascular-Endothelial-cell-specific Binding Peptide in Gastric Cancer

Selection of a Specific Binding Peptide Targeting to Blood Vessel of Human Gastric Cancer in Vivo and Modeling of Its Three Dimensional Structure

Screening of receptors of the peptide CGNSNPKSC that bind specifically to tumor vascular endothelium by immunoprecipitation and mass spectrometry

Imaging variation analysis of tumor vasculature homing peptide GX1 in colon cancer and lung cancer

Evaluation of 64cu Labeled GX1: A Phage Display Peptide Probe for PET Imaging of Tumor Vasculature

The further characterization of the peptide specifically binding to gastric cancer

In Vivo Magnetic Resonance and Fluorescence Dual-Modality Imaging of Tumor Angiogenesis in Rats Using GEBP11 Peptide Targeted Magnetic Nanoparticles.

[Preliminary Screening and Identification of a Peptide That Binds Specifically to Gastric Cancers Cells with High Metastasis to Peritoneum].

A Cy5.5-labeled Phage-Displayed Peptide Probe for Near-Infrared Fluorescence Imaging of Tumor Vasculature in Living Mice

Specific Phage-Displayed Peptides Binding to Tumor Vasculature

Identification of the receptor of CGNSNPKSC and its expression in gastric cancer

The selection and characterization of the peptides binding to the cells and tissues of gastric carcinoma

GX1-conjugated Poly(lactic Acid) Nanoparticles Encapsulating Endostar for Improved in Vivo Anticolorectal Cancer Treatment